VeriSign (VRSN) To Report Q2 Earnings: What's In Store?
Zacks Investment Research | Jul 21, 2019 11:10PM ET
VeriSign (NASDAQ:VRSN) is set to report second-quarter 2019 results on Jul 25.
Notably, the company’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, the average positive surprise being 10.8%.
VeriSign VeriSign, Inc. Quote
Moreover, on May 30, 2019, VeriSign announced that first-quarter 2019 closed with 351.8 million domain name registrations across all top-level domains (TLDs), up 0.9% year over year. Domain name registrations grew 18 million or 5.4% year over year.
However, increasing operating expenses related to research and development, and sales and marketing may prove to be a drag on margins in second-quarter 2019.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) along with a positive the complete list of today’s Zacks #1 Rank stocks here .
Apple (NASDAQ:AAPL) has an Earnings ESP of +1.35% and a Zacks Rank #3.
Grubhub (NYSE:GRUB) has a Zacks Rank #3 and an Earnings ESP of +23.79%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Zacks Investment Research
Get The News You Want